XML 48 R36.htm IDEA: XBRL DOCUMENT v3.23.2

Acquisitions (Tables)

6 Months Ended

Jun. 30, 2023

Business Combination and Asset Acquisition [Abstract]

Schedule of purchase price allocation

The following table summarizes the consideration paid for the BioPhero acquisition and the amounts of the assets acquired and liabilities assumed.

Purchase Price Allocation
(in Millions)
Fair Value of Assets Acquired
Cash			$	10.0
Intangible assets
Developed Technology (1)			66.3
In-process research & development			10.5
Goodwill			130.7
Other Assets			3.4
Total Assets			$	220.9
Fair Value of Liabilities Assumed
Deferred income tax liabilities			$	16.6
Other Liabilities			1.1
Total Liabilities			17.7
Net Assets			$	203.2
Total Purchase Consideration:			Amount
Cash purchase price, net of acquired cash			$	193.2
____________________
(1) Expected life is 15 years and will be amortized based on the pattern of economic benefit

X

- References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationAndAssetAcquisitionAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Paragraph 1
-Section 50
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479907/805-20-50-1

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration